title: Movement toward optimization of CLL therapy.
authors.affiliation: From the Hofstra North Shore-LIJ School of Medicine and the North Shore-LIJ Cancer Institute - both in Lake Success, NY; and the Feinstein Institute for Medical Research, Manhasset, NY.
authors.forename: Kanti R
authors.initials: KR
authors.lastname: Rai
authors.forename: Jacqueline C
authors.initials: JC
authors.lastname: Barrientos
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D018951:Antigens, CD20 / Q000276:immunology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002699:Chlorambucil / Q000008:administration & dosage*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20; D002699:Chlorambucil; C543332:obinutuzumab